Omega Therapeutics, Inc.
OMGADelisted Mar 20, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850838
Omega Therapeutics, Inc. was delisted on Mar 20, 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Omega Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 70 | 68 | −2 |
| Shares | 51.1M | 50.6M | −564.1K (−1.1%) |
| Value | $186.6M | $104.7M | −$82.0M (−43.9%) |
New holders (21)
Institutions that held Omega Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 222,395 | $460.4K | 0.00% |
| Jane Street Group, LLC | 213,497 | $441.9K | 0.00% |
| Renaissance Technologies LLC | 128,400 | $265.8K | 0.00% |
| Long Corridor Asset Management Ltd | 85,000 | $175.9K | 0.17% |
| XTX Topco Ltd | 83,939 | $173.8K | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 77,417 | $160.3K | 0.01% |
| Two Sigma Investments, LP | 73,722 | $152.6K | 0.00% |
| HRT Financial LP | 55,847 | $115.0K | 0.00% |
| Centiva Capital, LP | 43,800 | $90.7K | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 38,167 | $79.0K | 0.00% |
| Marex Group plc | 36,080 | $74.7K | 0.00% |
| Paloma Partners Management Co | 27,700 | $57.3K | 0.00% |
| Ground Swell Capital, LLC | 19,170 | $39.7K | 0.04% |
| Mirae Asset Global ETFs Holdings Ltd. | 13,016 | $26.9K | 0.00% |
| Schonfeld Strategic Advisors LLC | 11,700 | $24.2K | 0.00% |
| Camden Capital, LLC | 10,000 | $20.7K | 0.00% |
| Catalyst Funds Management Pty Ltd | 6,100 | $12.6K | 0.00% |
| Steward Partners Investment Advisory, LLC | 2,000 | $4.14K | 0.00% |
| Macquarie Group Ltd | 1,227 | $2.54K | 0.00% |
| Gradient Investments LLC | 900 | $1.86K | 0.00% |
| SRS Capital Advisors, Inc. | 54 | $112 | 0.00% |
Sold out (23)
Institutions that held Omega Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.